A carregar...
A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation
Proliferative vitreoretinopathy (PVR) is a blinding eye disease and there is no effective pharmacological measure to prevent PVR development. The difficulty comes from lack of potent antiproliferative agent and lack of sustained delivery to cover high-risk time window for PVR to develop. Lipid prodr...
Na minha lista:
| Publicado no: | Drug Deliv |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8241053/ https://ncbi.nlm.nih.gov/pubmed/29115885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2017.1399303 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|